Skip to main content
Premium Trial:

Request an Annual Quote

NextCode Health, Simons Foundation Partner to Increase Access to Autism Data

NEW YORK (GenomeWeb) – NextCode Health and the Simons Foundation Autism Research Initiative (SFARI) said today they have formed a partnership to help speed sequencing-related autism research.

Under the partnership, the Simons Simplex Collection (SSC), sequence and phenotypic datasets from nearly 2,600 families, will be available on NextCode Exchange, a newly launched genomic data analysis and collaboration service.

The SSC dataset is designed to support the discovery of rare, de novo genetic events that increase risk of developing autism spectrum disorders. The collection consists of 2,600 'simplex' families, all of which have one child with autism, unaffected parents, and usually at least one unaffected sibling. Sequencing of SSC data has already yielded 100 candidate genes for autism.

"Early analyses of this rich dataset have been very informative, but we know that there is a great deal more still to be learned from it," Alan Packer, senior scientist at SFARI said in a statement. "Providing the SSC data to the broader autism research community in this format is another way SFARI can pursue its mission of driving rapid scientific progress in the field of autism."

By making the data available on NextCode Exchange, "our aim is … to make the SSC even more accessible and valuable, enabling even more scientists to use it and … to accelerate discovery while saving on the time and expense of having to copy and send raw sequence," Jeffrey Gulcher, president, chief scientific officer and co-founder of NextCode, added.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.